166 related articles for article (PubMed ID: 19444936)
1. Recent advances in 17beta-hydroxysteroid dehydrogenases.
Prehn C; Möller G; Adamski J
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):72-7. PubMed ID: 19444936
[TBL] [Abstract][Full Text] [Related]
2. 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.
Marchais-Oberwinkler S; Henn C; Möller G; Klein T; Negri M; Oster A; Spadaro A; Werth R; Wetzel M; Xu K; Frotscher M; Hartmann RW; Adamski J
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):66-82. PubMed ID: 21193039
[TBL] [Abstract][Full Text] [Related]
3. Multifunctionality of human 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2006 Mar; 248(1-2):47-55. PubMed ID: 16413960
[TBL] [Abstract][Full Text] [Related]
4. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease.
Meier M; Möller G; Adamski J
Ann N Y Acad Sci; 2009 Feb; 1155():15-24. PubMed ID: 19250188
[TBL] [Abstract][Full Text] [Related]
5. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
Day JM; Tutill HJ; Purohit A; Reed MJ
Endocr Relat Cancer; 2008 Sep; 15(3):665-92. PubMed ID: 18541621
[TBL] [Abstract][Full Text] [Related]
6. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.
Shafqat N; Marschall HU; Filling C; Nordling E; Wu XQ; Björk L; Thyberg J; Mårtensson E; Salim S; Jörnvall H; Oppermann U
Biochem J; 2003 Nov; 376(Pt 1):49-60. PubMed ID: 12917011
[TBL] [Abstract][Full Text] [Related]
7. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.
Baker ME
Mol Cell Endocrinol; 2001 Jan; 171(1-2):211-5. PubMed ID: 11165032
[TBL] [Abstract][Full Text] [Related]
8. Integrated view on 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):7-19. PubMed ID: 19027824
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of 17 beta-hydroxysteroid dehydrogenases.
Poirier D
Curr Med Chem; 2003 Mar; 10(6):453-77. PubMed ID: 12570693
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
11. Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases.
Poirier D
Anticancer Agents Med Chem; 2009 Jul; 9(6):642-60. PubMed ID: 19601747
[TBL] [Abstract][Full Text] [Related]
12. Subcellular localization and membrane topology of 17β-hydroxysteroid dehydrogenases.
Tsachaki M; Odermatt A
Mol Cell Endocrinol; 2019 Jun; 489():98-106. PubMed ID: 30864548
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression and characterization of three types of 17beta-hydroxysteroid dehydrogenases from the Nile tilapia, Oreochromis niloticus.
Zhou LY; Wang DS; Senthilkumaran B; Yoshikuni M; Shibata Y; Kobayashi T; Sudhakumari CC; Nagahama Y
J Mol Endocrinol; 2005 Aug; 35(1):103-16. PubMed ID: 16087725
[TBL] [Abstract][Full Text] [Related]
14. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase.
Luu-The V
J Steroid Biochem Mol Biol; 2001; 76(1-5):143-51. PubMed ID: 11384872
[TBL] [Abstract][Full Text] [Related]
15. Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues.
Labrie F; Luu-The V; Lin SX; Simard J; Labrie C
Trends Endocrinol Metab; 2000 Dec; 11(10):421-7. PubMed ID: 11091120
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
17. 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
Poirier D
Expert Opin Ther Pat; 2010 Sep; 20(9):1123-45. PubMed ID: 20645882
[TBL] [Abstract][Full Text] [Related]
18. Distribution of 17beta-hydroxysteroid dehydrogenases in human osteoblast-like cells.
Feix M; Wolf L; Schweikert HU
Mol Cell Endocrinol; 2001 Jan; 171(1-2):163-4. PubMed ID: 11165024
[TBL] [Abstract][Full Text] [Related]
19. 17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease.
Wang MX; Peng ZG
Pharmacol Ther; 2023 Jun; 246():108428. PubMed ID: 37116587
[TBL] [Abstract][Full Text] [Related]
20. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
